Status:
COMPLETED
Telecare in Type 1 Diabetes (T1D) Patients Treated by Insulin Pump
Lead Sponsor:
Assuta Hospital Systems
Collaborating Sponsors:
Maccabi Healthcare Services, Israel
Conditions:
Type 1 Diabetes Mellitus
Eligibility:
All Genders
22+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether Telecare can be used for efficient management of adults with Type 1 Diabetes Mellitus using insulin pump, in lieu of frequent clinic visits.
Detailed Description
1. Objectives 1. To evaluate the effect of telecare on glycemic control for patients with type 1 diabetes (T1DM). 2. To assess the cost of telecare to Maccabi, the patient and the economy. 3...
Eligibility Criteria
Inclusion
- Patients with T1D lasted \>1 year, age 22 and up, using insulin pump
- Patients possessing a mobile phone and internet access
Exclusion
- Patients with Severe target organ damage
- Patients with Mental retardation
- Patients with Eating disorders
- Pregnant patients or patients planning pregnancy
Key Trial Info
Start Date :
October 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2016
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT01887431
Start Date
October 1 2013
End Date
November 1 2016
Last Update
January 31 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maccabi Healthcare Services
Raanana, Israel